About us

Há Biotech bridges marine biology and medicine to revolutionize fish farming, creating sustainable solutions for the aquaculture industry. By addressing critical challenges like spawning disruption, fish escapes, and ecological risks, we aim to make fish farming both environmentally and economically sustainable while protecting wild fish populations. Through advanced immunological interventions, our mission is to transform aquaculture into a cornerstone of sustainable food production, meeting global protein demands responsibly.

Team

Board

Investors

Havland
Sarsia

A 70-year timeline

From early experiments to modern genetic innovations

1950
First attempts to induce sterility in fish using gonadectomy and radiation.
1970
Early success of coho salmon sea cage culture in Washington State.
1971
Development of triploidy induction methods for fish sterility.
1980
Widespread use of triploidy for sterility induction in aquaculture.
1989
Engineering of the growth hormone transgenic 'AquAdvantage' Atlantic salmon.
1990
Increase in Atlantic salmon imports to the US, from 19.2 thousand tonnes.
2000
Significant advancements in molecular and genetic tools for aquaculture.
2015
US FDA approval of 'AquAdvantage' Atlantic salmon for human consumption.
2017
Major escape event of 250,000 Atlantic salmon in Washington State.
2018
Global aquaculture production of fish surpasses capture fisheries used for human consumption.
2019
Major escape event of 20,000 Atlantic salmon in British Columbia.
2022
Washington State phases out aquaculture of non-native finfish species.
keyboard_arrow_up